1. Home
  2. HLST
  3. HLST 405: Medical Treatment: Evaluating Cost and Effectiveness

HLST 405: Medical Treatment: Evaluating Cost and Effectiveness Report a Broken Link

Unit 3

Required Readings
Kahn, R., Robertson, R. M., Smith, R., & Eddy, D. (2008). The impact of prevention on reducing the burden of cardiovascular disease. Circulation, 118(5), 576–585.DOI: 10.1161/CIRCULATIONAHA.108.190186
Maciosek, M. V., Coffield, A. B., Edwards, N. M., Flottemesch, T. J., Goodman, M. J., & Solberg, L. I. (2006). Priorities among effective clinical preventive services: Results of a systematic review and analysis. American Journal of Preventive Medicine, 31(1), 52–61.

Unit 5

Supplementary Readings
Morgan, S. G., Bassett, K. L., Wright, J. M., Evans, R. G., Barer, M. L., Caetano, P. A., et al. (2005). “Breakthrough” drugs and growth in expenditure on prescription drugs in Canada. BMJ (British Medical Journal) 331(7520), 815-816.

Unit 8

Supplementary Readings
Bill-Axelson A., Holmberg, L., Filén, F., Ruutu, M., Garmo. H., Busch, C., et al. (2008). Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial. Journal of the National Cancer Institute, 100(16), 1144–1154.
Cohen, J. T., Neumann, P. J., & Weinstein, M. C. (2008). Does preventive care save money? Health economics and the presidential candidates. New England Journal of Medicine, 358(7), 661–663.

Unit 10

Supplementary Readings
Keenan, P. S. (2009). Smoking and weight change after new health diagnoses in older adults. Archives of Internal Medicine, 169(3), 237–242.

Unit 11

Required Readings
Pearson, S. D., & Rawlins, M. D. (2005). Quality, innovation, and value for money: NICE and the British National Health Service. Journal of the American Medical Association, 294, 2618–2622.
Supplementary Readings
Temple, N. J. (2007). Spiralling medical costs: Why Canada needs NICE medicine. Healthcare Policy, 3(2), 38–47.